Biomoda to Participate and Present at the OneMedPlace Finance Forum

As a follow up to completing patient enrollment and sample collection in connection with its Phase II pilot study, John Cousins, President and CEO of Biomoda, Inc. (OTCBB: BMOD), is presenting its proprietary CyPath® diagnostic assay for the detection of early-stage cancers at OneMedPlace’s mid-year finance forum in New York on Wednesday, June 30, 2010.  Cousins’ presentation will be Webcast at approximately 3:20pm Eastern Daylight Time on Wednesday, June 30th, and can be viewed live online by clicking here.

Read More

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: